Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort.

Teenage girl sad and thoughtful looking out of a window

The grant will be made available through the Westminster Foundation to support the University’s Department of Psychiatry, which is at the forefront of mental health research in the UK. They are addressing a broad range of mental health issues arising from the pandemic and its impacts on the human psyche, including isolation, confinement, uncertainty, anxiety, stress and the disconnection from our social, family and work lives.

The effect of the pandemic on the mental well-being of children is of particular concern and interest to the Duke, and Westminster Foundation, which provides long-term support to vulnerable young people and families.

The University’s mental health researchers are developing diagnostic tools and crafting expert guidance for governments, schools, parents, medical professionals, therapists, carers and individuals. For example, Oxford is working with thousands of local families to track children and young people’s mental health throughout the COVID-19 crisis. The results will help researchers identify what protects children and young people from deteriorating mental health over time and at particular stress points, and how this may vary according to child and family characteristics. A team of psychiatrists and researchers are also developing a set of resources to help communicate parental illness and death to children.

Read the full story on the University of Oxford website

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.